| 12392784 |
Method of assessing risk of PML |
Gary Lewis Bloomgren, Carmen Bozic, Sophia Lee, Amy Pace, Meena Subramanyam |
2025-08-19 |
| 12385925 |
Anti-VLA-4 related assays |
Paula S. Hochman, Michaela Lerner |
2025-08-12 |
| 12105090 |
Methods of treating a multiple sclerosis patient with anti-VLA-4 therapy |
Gary Lewis Bloomgren, Carmen Bozic, Sophia Lee, Meena Subramanyam |
2024-10-01 |
| 12066442 |
Method of assessing risk of PML |
Gary Lewis Bloomgren, Carmen Bozic, Sophia Lee, Meena Subramanyam |
2024-08-20 |
| 12031990 |
Method of assessing risk of PML |
Gary Lewis Bloomgren, Carmen Bozic, Sophia Lee, Amy Pace, Meena Subramanyam |
2024-07-09 |
| 11686730 |
Quantitative antibody test |
Andrew Ball, Lei Chang, Syrena C. Fernandes, Joe Johnson, Jeremy Lambert +2 more |
2023-06-27 |
| 11280794 |
Method of assessing risk of PML |
Gary Lewis Bloomgren, Carmen Bozic, Sophia Lee, Amy Pace, Meena Subramanyam |
2022-03-22 |
| 11280793 |
Anti-VLA-4 related assays |
Paula S. Hochman, Michaela Lerner |
2022-03-22 |
| 10955422 |
Method of assessing risk of PML |
John Carulli, Leonid Gorelik, Teresa Compton |
2021-03-23 |
| 10677803 |
Method of assessing risk of PML |
Gary Lewis Bloomgren, Carmen Bozic, Sophia Lee, Amy Pace, Meena Subramanyam |
2020-06-09 |
| 10302654 |
Anti-VLA-4 related assays |
Paula S. Hochman, Michaela Lerner |
2019-05-28 |
| 10119976 |
Method of assessing risk of PML |
Gary Lewis Bloomgren, Carmen Bozic, Sophia Lee, Amy Pace, Meena Subramanyam |
2018-11-06 |
| 9726672 |
Anti-VLA-4 related assays |
Paula S. Hochman, Michaela Lerner |
2017-08-08 |
| 9377458 |
Anti-VLA-4 related assays |
Paula S. Hochman, Michaela Lerner |
2016-06-28 |